Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension
Wolfgang H. Oertel(Philipps University of Marburg), V. Schumann(Saint Göran Hospital), Peter Geisler, Michael Hopp(Johannes Gutenberg University Mainz), Ines Peglau, Michael Lang(Paracelsus Elena Klinik Kassel), Abraham Mahler(Paracelsus Elena Klinik Kassel), Svenja Happe(Klinikum Bremen-Mitte), Boris-Alexander Kallmann(Medical University of Vienna), G. Karlbauer(Mundipharma (Germany)), B Gestewitz(Mundipharma (Germany)), Birgit Högl(Innsbruck Medical University), J. Haan(Mundipharma (Germany)), Bettina Bergtholdt(Emovis), Gert Mayer(University of Vienna), Joachim Koppai-Reiner(Mundipharma (Germany)), Ralf Bodenschatz(Mundipharma (Germany)), Peter Franz(University of Vienna), W. Lüer(Paracelsus Elena Klinik Kassel), Rebecca Bitter(Paracelsus Elena Klinik Kassel), Stephan Behrens(Mundipharma (Germany)), Irma Schöll, Almut Schulze(German Cancer Research Center), Magdolna Hornyak(University Medical Center Freiburg), M. J. Klein(Mundipharma (Germany)), Paul E. Donat(Paracelsus Elena Klinik Kassel), Jack S. Peltz(SUNY Brockport), Heike Beneš(Siesta Group (Austria)), William D. Mattern(Medical University of Vienna), Jan Kassubek(Universität Ulm), Cath Roper(The University of Melbourne), R. Leibinger(Paracelsus Elena Klinik Kassel), K. Sallach(Paracelsus Elena Klinik Kassel), H. Henin(Mundipharma (Germany)), W. Molt(Philipps University of Marburg), E. Rüttgers(Paracelsus Elena Klinik Kassel), J. Böhringer, W. Lünser, Stefan Braune(Metrogiprotrans (Russia)), A. Hufnagel, H.-J. Gertz(Mundipharma (Germany)), H.-J. Boldt(Mundipharma (Germany)), Björn Bosse(Mundipharma (Germany)), G. Saletu‐Zyhlarz(Vienna General Hospital), Yngve Hallström(Saint Göran Hospital), Claudia Trenkwalder(Paracelsus Elena Klinik Kassel), I. Fietze(Mundipharma (Germany))
Cited by 23
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Lipid metabolism in cancer
|FEBS Journal|2012|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study
|Movement Disorders|2012|460
Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy
|Nature Communications|2018|406